Edition:
India

Enzo Biochem Says CO Considering All Available Options For Challenging Federal Circuit Panel's Decision


Saturday, 22 Jun 2019 

June 21 (Reuters) - Abbott Laboratories ::ENZO BIOCHEM - U.S. COURT OF APPEALS ISSUED OPINION AFFIRMING LOWER COURT JUDGMENTS OF PATENT INVALIDITY FOR U.S. PATENT NOS. 6,992,180 & 8,097,405.ENZO BIOCHEM INC - COMPANY IS CONSIDERING ALL AVAILABLE OPTIONS FOR CHALLENGING FEDERAL CIRCUIT PANEL'S DECISION. 

Company Quote

86.35
0.38 +0.44%
13 Dec 2019